POINT Biopharma Global Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.50
|
|
Average Rating
|
4.82
|
|
# Strong Buys
|
9
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.28
|
-0.26
|
0.02
|
7.14%
|
|
2022-06-30
|
-0.22
|
-0.27
|
-0.05
|
-22.73%
|
|
2022-03-31
|
-0.21
|
-0.18
|
0.03
|
14.29%
|
|
2021-12-31
|
-0.23
|
-0.16
|
0.07
|
30.43%
|
|
2021-09-30
|
-0.19
|
-0.19
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.11
|
-0.15
|
-0.04
|
-36.36%
|
|
2021-03-31
|
0.00
|
-0.08
|
0.00
|
0.00%
|
|
2020-12-31
|
0.00
|
-0.01
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.71
|
|
2021-12-31
|
-0.58
|
|
2020-12-31
|
-0.03
|